Anesthesia for the Pregnant Patient with Autoimmune Disorders

  • Rie KatoEmail author
  • Toshiyuki Okutomi


Autoimmune disorders are common in women at their childbearing age. This chapter discusses systemic lupus erythematosus, antiphospholipid syndrome, Sjögren’s syndrome, and rheumatoid arthritis. All of them affect pregnancy outcome, and therefore careful management should be started before conception. Anesthetic considerations are also important depending on the clinical pathology of an individual parturient. These disorders may deteriorate during pregnancy and can result in cardiac, pulmonary, and renal dysfunction. Platelet count in systemic lupus erythematosus and anticoagulation therapy in antiphospholipid syndrome should be checked. Airway assessment is crucial particularly in rheumatoid arthritis.


Systemic lupus erythematosus Antiphospholipid syndrome Sjögren’s syndrome Rheumatoid arthritis Anesthesia Thrombocytopenia Anticoagulation Interstitial pneumonia Pericarditis Nephritis 


  1. 1.
    Ben-Menachem E. Review article: systemic lupus erythematosus: a review for anesthesiologists. Anesth Analg. 2010;111:665–76.CrossRefGoogle Scholar
  2. 2.
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–7.CrossRefGoogle Scholar
  3. 3.
    Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.CrossRefGoogle Scholar
  4. 4.
    Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677–86.CrossRefGoogle Scholar
  5. 5.
    Pons-Estel GJ, Wojdyla D, McGwin G Jr, Magder LS, Petri MA, Pons-Estel BA, et al. The American College of Rheumatology and the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus in two multiethnic cohorts: a commentary. Lupus. 2014;23:3–9.CrossRefGoogle Scholar
  6. 6.
    Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005;52:514–21.CrossRefGoogle Scholar
  7. 7.
    Jara LJ, Medina G, Cruz-Dominguez P, Navarro C, Vera-Lastra O, Saavedra MA. Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res. 2014;60:184–92.CrossRefGoogle Scholar
  8. 8.
    Bjorkander S, Bremme K, Persson JO, van Vollenhoven RF, Sverremark-Ekstrom E, Holmlund U. Pregnancy-associated inflammatory markers are elevated in pregnant women with systemic lupus erythematosus. Cytokine. 2012;59:392–9.CrossRefGoogle Scholar
  9. 9.
    Stojan G, Baer AN. Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management. Expert Rev Clin Immunol. 2012;8:439–53.CrossRefGoogle Scholar
  10. 10.
    Clowse ME. Lupus activity in pregnancy. Rheum Dis Clin N Am. 2007;33:237–52.CrossRefGoogle Scholar
  11. 11.
    Moroni G, Ponticelli C. Pregnancy in women with systemic lupus erythematosus (SLE). Eur J Intern Med. 2016;32:7–12.CrossRefGoogle Scholar
  12. 12.
    Lazzaroni MG, Dall'Ara F, Fredi M, Nalli C, Reggia R, Lojacono A, et al. A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. J Autoimmun. 2016;74:106–17.CrossRefGoogle Scholar
  13. 13.
    Gogarten W, Vandermeulen E, Van Aken H, Kozek S, Llau JV, Samama CM. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol. 2010;27:999–1015.CrossRefGoogle Scholar
  14. 14.
    Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5:2060–8.CrossRefGoogle Scholar
  15. 15.
    Ko HS, Ahn HY, Jang DG, Choi SK, Park YG, Park IY, et al. Pregnancy outcomes and appropriate timing of pregnancy in 183 pregnancies in Korean patients with SLE. Int J Med Sci. 2011;8:577–83.CrossRefGoogle Scholar
  16. 16.
    Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76:476–85.CrossRefGoogle Scholar
  17. 17.
    Vinet E, Pineau CA, Clarke AE, Fombonne E, Platt RW, Bernatsky S. Neurodevelopmental disorders in children born to mothers with systemic lupus erythematosus. Lupus. 2014;23:1099–104.CrossRefGoogle Scholar
  18. 18.
    Bertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis. 2008;67:195–205.CrossRefGoogle Scholar
  19. 19.
    Peart E, Clowse ME. Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature. Curr Opin Rheumatol. 2014;26:118–23.CrossRefGoogle Scholar
  20. 20.
    Pons-Estel GJ, Andreoli L, Scanzi F, Cervera R, Tincani A. The antiphospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun. 2017;76:10–20.CrossRefGoogle Scholar
  21. 21.
    Arachchillage DRJ, Laffan M. Pathogenesis and management of antiphospholipid syndrome. Br J Haematol. 2017;178:181–95.CrossRefGoogle Scholar
  22. 22.
    Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.CrossRefGoogle Scholar
  23. 23.
    Schreiber K, Radin M, Sciascia S. Current insights in obstetric antiphospholipid syndrome. Curr Opin Obstet Gynecol. 2017;29:397–403.PubMedGoogle Scholar
  24. 24.
    Gomez-Puerta JA, Cervera R. Diagnosis and classification of the antiphospholipid syndrome. J Autoimmun. 2014;48–49:20–5.CrossRefGoogle Scholar
  25. 25.
    Arachchillage DR, Machin SJ, Mackie IJ, Cohen H. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome. Thromb Haemost. 2015;113:13–9.CrossRefGoogle Scholar
  26. 26.
    Keeling D, Mackie I, Moore GW, Greer IA, Greaves M, British Committee for Standards in H. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2012;157:47–58.CrossRefGoogle Scholar
  27. 27.
    Nelson-Piercy C, Maccallum P, Mackillop MA. Reducing the risk of venous thromboembolism during pregnancy and the puerperium. Green-top guideline. London: Royal College of Obstetricians & Gynaecologists; 2015.Google Scholar
  28. 28.
    Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e691S–736S.CrossRefGoogle Scholar
  29. 29.
    Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition). Reg Anesth Pain Med. 2010;35:64–101.CrossRefGoogle Scholar
  30. 30.
    Butwick AJ, Carvalho B. Anticoagulant and antithrombotic drugs in pregnancy: what are the anesthetic implications for labor and cesarean delivery? J Perinatol. 2011;31:73–84.CrossRefGoogle Scholar
  31. 31.
    Upala S, Yong WC, Sanguankeo A. Association between primary Sjogren’s syndrome and pregnancy complications: a systematic review and meta-analysis. Clin Rheumatol. 2016;35:1949–55.CrossRefGoogle Scholar
  32. 32.
    Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76:9–16.CrossRefGoogle Scholar
  33. 33.
    Klein-Gitelman MS. Neonatal lupus: what we have learned and current approaches to care. Curr Rheumatol Rep. 2016;18:60.CrossRefGoogle Scholar
  34. 34.
    Isaacs JD, Moreland LW. Fast facts: rheumatoid arthritis. 2nd ed. Abington: Health Press; 2011.CrossRefGoogle Scholar
  35. 35.
    Marder W, Littlejohn EA, Somers EC. Pregnancy and autoimmune connective tissue diseases. Best Pract Res Clin Rheumatol. 2016;30:63–80.CrossRefGoogle Scholar
  36. 36.
    Gotestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75:795–810.CrossRefGoogle Scholar
  37. 37.
    Aires RB, de Carvalho JF, da Mota LM. Pre-operative anesthetic assessment of patients with rheumatoid arthritis. Rev Bras Reumatol. 2014;54:213–9.CrossRefGoogle Scholar
  38. 38.
    Samanta R, Shoukrey K, Griffiths R. Rheumatoid arthritis and anaesthesia. Anaesthesia. 2011;66:1146–59.CrossRefGoogle Scholar
  39. 39.
    Hollan I, Dessein PH, Ronda N, Wasko MC, Svenungsson E, Agewall S, et al. Prevention of cardiovascular disease in rheumatoid arthritis. Autoimmun Rev. 2015;14:952–69.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Obstetric Anesthesia, Center for Perinatal Care, Child Health and DevelopmentKitasato University HospitalSagamiharaJapan

Personalised recommendations